In cases of sepsis, including bacterial sepsis and viral conditions like COVID-19 (coronavirus disease-2019), aberrant activation of the NLRP3 inflammasome has also been documented mostly through the measurement of increased plasmatic concentrations of IL-1β and IL-18 [8,9,10,11]. This evidence concerns the gene NLRP3 and COVID-19.